U-Neuron Biomedical Stock

U-Neuron Biomedical EBITDA per Share

The EBITDA per Share of U-Neuron Biomedical (6973.TWO) as of Aug 13, 2026 is -2.01 TWD. In the previous year, EBITDA per Share was -3.34 TWD — a change of -39.86% (higher).

EBITDA per Share

-2.01TWD

YoY

-39.86%

Last updated:

EBITDA per Share of U-Neuron Biomedical is 2026 -2.01 TWD. EBITDA per Share of U-Neuron Biomedical was 2025 -3.34 TWD. It decreases by -39.86% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

EBITDA per Share of U-Neuron Biomedical is -2.01 TWD in 2026.

EBITDA per Share of U-Neuron Biomedical changed from -3.34 TWD to -2.01 TWD, representing a -39.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share U-Neuron Biomedical since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — U-Neuron Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — U-Neuron Biomedical